(Q42455463)

English

Intratumoral injection of IL-2-activated NK cells enhances the antitumor effect of intradermally injected paraformaldehyde-fixed tumor vaccine in a rat intracranial brain tumor model

scientific article published on January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Intratumoral injection of IL-2-activated NK cells enhances the antitumor effect of intradermally injected paraformaldehyde-fixed tumor vaccine in a rat intracranial brain tumor model (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

1 reference

based on heuristic

inferred from title

author name string

Eiichi Ishikawa

1

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Koji Tsuboi

2

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Shingo Takano

3

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Eiji Uchimura

4

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Tadao Nose

5

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Tadao Ohno

6

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

95

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

98-103

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03177.X

21 January 2018

Reduction of end-stage malignant glioma by injection with autologous cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03177.X

21 January 2018

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03177.X

21 January 2018

Maintenance of remission in acute myelogenous leukaemia by a mixture of B.C.G. and irradiated leukaemia cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03177.X

21 January 2018

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03177.X

21 January 2018

Autologous fixed tumor vaccine: a formulation with cytokine-microparticles for protective immunity against recurrence of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03177.X

21 January 2018

The immune system and the nervous system.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03177.X

21 January 2018

Evidence of focal genetic microheterogeneity in glioblastoma multiforme by area-specific CGH on microdissected tumor cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03177.X

21 January 2018

Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03177.X

21 January 2018

Local tumor irradiation augments the antitumor effect of cytokine-producing autologous cancer cell vaccines in a murine glioma model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03177.X

21 January 2018

Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03177.X

21 January 2018

Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03177.X

21 January 2018

Intratumoral injection of dendritic and irradiated glioma cells induces anti-tumor effects in a mouse brain tumor model.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03177.X

21 January 2018

Intratumoral injection of dendritic cells after treatment of anticancer drugs induces tumor-specific antitumor effect in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03177.X

21 January 2018

In vivo natural killer cell activities revealed by natural killer cell-deficient mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03177.X

21 January 2018

Reciprocal activating interaction between natural killer cells and dendritic cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03177.X

21 January 2018

Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03177.X

21 January 2018

Fractalkine-mediated endothelial cell injury by NK cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03177.X

21 January 2018

The enigma of the natural killer cell

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03177.X

21 January 2018

P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificitie

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03177.X

21 January 2018

Selective expansion of human natural killer cells from peripheral blood mononuclear cells by the cell line, HFWT.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB03177.X

21 January 2018

Identifiers

10.1111/J.1349-7006.2004.TB03177.X

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42455463&oldid=1958089587"